New Insights into COVID-19: Epidemiology, Prevention, Diagnosis, and Treatment of SARS-CoV-2, and New Variants
A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Coronaviruses (CoV) and COVID-19 Pandemic".
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 18343
Special Issue Editors
Interests: public health; epidemiology; infectious diseases; vaccination; vaccine effectiveness; communicable diseases
Special Issues, Collections and Topics in MDPI journals
Interests: public health; epidemiology; immunology; infectious diseases; vaccination; vaccine effectiveness; communicable diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The coronavirus disease 2019 (COVID-19) has certainly had an incomparable health, social, and economic impact on a global scale. Since its first detection in Wuhan, China, in December 2019, the epidemic spread so rapidly to countries around the world that the World Health Organization (WHO) had to declare the pandemic status a few months later, on 11 March 2020. SARS-CoV-2 infection may determine a broad clinical spectrum that ranges from asymptomatic infection to distinct clinical manifestations, namely asthenia, fever, chills, cough, shortness of breath, sore throat, diarrhea, dysgeusia, loss of appetite, dysosmia, and respiratory symptoms. Much attention was focused on the spread of this viral infection: after several months, it was the advent of COVID-19 vaccines that significantly controlled both the spread and the severity of SARS-CoV-2-infection-related outcomes.
The COVID-19 pandemic, unfortunately, was complicated by SARS-CoV-2 genetic evolution, an adaptive response to human hosts’ defenses that progressively contributed to the selection of different variants. Some of these variants have been defined by the WHO as variants of concern (VOCs) because of their greater transmissibility or virulence and, secondarily, due to the reduced neutralizing activity of the antibodies produced both from natural infection and vaccination. As a result, the effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and COVID-19 may have been altered.
Accordingly, the aim of the Special Issue is to provide an updated scenery of the COVID-19 pandemic, exploring the general epidemiology of this continuously evolving virus, establishing and evaluating disease diagnosis, treatment, and prevention and control strategies, assessing the impact of public health interventions, including communication strategies, inspecting the impact of VOC among SARS-CoV-2 infected subjects, and evaluating the effectiveness over time of COVID-19 vaccines.
We look forward to receiving contributions on these topics.
Dr. Emanuele Amodio
Dr. Dario Genovese
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- coronavirus
- SARS-CoV-2
- viral infections
- pandemic
- public health
- epidemiology
- vaccine effectiveness
- variants
- variants of concern
- long-COVID
- diagnosis
- testing
- prevention
- treatment
- recovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.